Precigen (PGEN) Interest Coverage Ratio Growth (3y) (2015 - 2026)
Precigen (PGEN) Interest Coverage Ratio Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Precigen |
1.32 Bn |
1.32 Bn |
20.69 Mn |
69.47% |
| Date | Value |
|---|
| Mar 31, 2026 |
69.47% |
| Dec 31, 2025 |
40.22% |
| Sep 30, 2025 |
-117.03% |
| Mar 31, 2025 |
-1,176.25% |
| Sep 30, 2024 |
-1,230.04% |
| Jun 30, 2024 |
-1,651.81% |
| Mar 31, 2024 |
-1,363.10% |
| Dec 31, 2023 |
-1,247.35% |
| Sep 30, 2023 |
-411.44% |
| Jun 30, 2023 |
-45.37% |
| Mar 31, 2023 |
-171.65% |
| Dec 31, 2022 |
50.95% |
| Sep 30, 2022 |
70.76% |
| Jun 30, 2022 |
-33.33% |
| Mar 31, 2022 |
-3.79% |
| Dec 31, 2021 |
-27.37% |
| Sep 30, 2021 |
32.34% |
| Jun 30, 2021 |
71.53% |
| Mar 31, 2021 |
79.10% |
| Dec 31, 2020 |
81.35% |
